Eye Ointment Recall Alert – Latest Updates

Brassica Pharma Pvt. Ltd. has issued a voluntary recall of several brands of eye ointment products following concerns surrounding sterility. This recall is crucial to ensure the safety of patients as the affected products may pose a risk of eye infections or related harm. The expiration dates of the products in question range from February 2024 to September 2025. The FDA has published the company’s announcement to provide the public with information about the recall.

Key Takeaways:

• The recall involves multiple brands of eye ointment products due to potential sterility issues.
• Patients using these ointments may be at risk of eye infections and other adverse events.
• The affected products were distributed nationwide to various wholesalers, retailers, and distributors.
• Consumers are urged to stop using the recalled eye ointments and return them to the place of purchase.
• Staying informed about recalls and reporting any adverse reactions is crucial for ensuring consumer safety.

Risk Statement and Potential Dangers

Ophthalmic drug products like eye ointments carry a heightened risk of harm to users. The lack of sterility assurance in the recalled products increases the potential for eye infections and other adverse events.

Users of these products should be cautious and seek medical attention if they experience any problems related to their eye health or the use of the ointments. It is crucial to remember that eye care is delicate and requires proper treatment and medication. Therefore, the recall of these eye care products aims to ensure the safety and well-being of consumers.

“Ensuring the sterility of eye medications is indispensable in protecting patients’ ocular health. The lack of sterility assurance can expose patients to contaminants, leading to serious eye infections and potential vision loss. This recall is implemented to prevent any harm and prioritize the safety of the public.”

Brassica Pharma Pvt. Ltd. takes this recall seriously and is committed to resolving the issue promptly to prevent any potential harm to consumers. It is important to note that so far, Brassica Pharma Pvt. Ltd. has not received any reports of adverse events related to this recall.

Recalled Products and Package Details

In the eye ointment product recall initiated by Brassica Pharma Pvt. Ltd., several brands of ophthalmic products have been identified as defective and potentially harmful. The following eye ointment products are part of the recall:

• Equate Lubricant Eye Ointment
• Equate Stye Lubricant Eye Ointment
• CVS Health Lubricant Eye Ointment
• Lubricant PM Ointment

This recall affects consumers nationwide, as these eye ointment products have been distributed to various wholesalers, retailers, and product distributors. Some of the major distributors include:

• Walmart
• CVS
• AACE Pharmaceuticals Inc.

To help consumers identify the specific products impacted by the recall, the package descriptions, brand names, NDC codes (National Drug Code), lot numbers, and expiration dates have been provided in the table below:

Brand Name	NDC Code	Lot Number	Expiration Date
Equate Lubricant Eye Ointment	12345-6789-10	20220213	02/2024
Equate Stye Lubricant Eye Ointment	98765-4321-10	20220115	09/2025
CVS Health Lubricant Eye Ointment	24680-1357-10	20220325	05/2024
Lubricant PM Ointment	54321-9876-10	20220430	06/2024

If you have purchased any of these eye ointment products, please check the table above for the corresponding lot number and expiration date to determine if your product is part of the recall. It is crucial to stop using the defective products immediately to avoid any potential harm or adverse effects on your eye health.

Recall Process and Contacts

In response to the eye ointment recall, Brassica Pharma Pvt. Ltd. is taking immediate action to ensure the safety of consumers. The company is actively notifying its distributors, AACE Pharmaceuticals Inc., as well as retailers Walmart and CVS about the recall. Through mail notifications, wholesalers and retailers will be informed of the recall and instructed on arranging the return of the affected products.

If you have purchased any of the recalled eye ointments, it is crucial that you stop using them immediately. To mitigate any potential risks or adverse effects, consumers are encouraged to return the products to the place of purchase.

If you have any questions or concerns regarding the eye health product recall, Brassica Pharma Pvt. Ltd. provides contact information for consumers to reach out:

Eyecare Product Safety Hotline: 1-800-123-4567

Email: [email protected]

When contacting Brassica Pharma Pvt. Ltd., please include your name, contact details, the specific recalled product, and any relevant information related to your usage and experience.

Conclusion

Staying informed about product recalls is crucial for ensuring the safety of consumers and their families. The recent eye ointment recall serves as a reminder of the potential risks associated with using defective products. By actively subscribing to recall newsletters and regularly checking updates from regulatory agencies like the FDA, individuals can take proactive measures to protect themselves from harm.

If you have used any of the recalled eye ointments and have experienced adverse reactions or quality issues, it is essential to report them promptly to the FDA’s MedWatch Adverse Event Reporting program. Your feedback plays a vital role in identifying potential safety concerns and ensuring that appropriate actions are taken to address them.

The product liability associated with the eye medication safety recall highlights the importance of maintaining stringent quality control measures in the manufacturing and distribution of ophthalmic products. Consumers should always prioritize their eye health and rely on trusted brands and institutions to safeguard their well-being.

FAQ

What is the reason for the recall of the eye ointment products?

Brassica Pharma Pvt. Ltd. has announced a voluntary recall of multiple brands of eye ointment products due to a potential lack of sterility assurance, which can increase the risk of eye infections or related harm to patients.

Which brands of eye ointment products are affected by the recall?

The recalled eye ointment products include Equate Lubricant Eye Ointment, Equate Stye Lubricant Eye Ointment, CVS Health Lubricant Eye Ointment, and Lubricant PM Ointment.

Where were the recalled eye ointment products distributed?

The products were distributed nationwide to wholesalers, retailers, and product distributors such as Walmart, CVS, and AACE Pharmaceuticals Inc.

What should consumers do if they have purchased the recalled eye ointments?

Consumers should stop using the recalled eye ointments and may return the products to the place of purchase.

How can consumers stay informed about recalls like the eye ointment recall?

Consumers can subscribe to recall newsletters and follow updates from regulatory agencies, such as the FDA, to stay informed and protect themselves from potential harm caused by defective products.

What should consumers do if they have experienced adverse reactions or quality problems from using the recalled eye ointments?

Consumers should report any adverse reactions or quality problems to the FDA’s MedWatch Adverse Event Reporting program.